Cargando…

Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance

Detalles Bibliográficos
Autores principales:	Trinks-Roerdink, Emmy M., Geersing, Geert-Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336188/ https://www.ncbi.nlm.nih.gov/pubmed/37449054 http://dx.doi.org/10.1016/j.rpth.2023.100199

Ejemplares similares

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Antithrombotic management of patients with atrial fibrillation—Dutch anticoagulant initiatives anno 2020
por: Chu, G., et al.
Publicado: (2020)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Hospitalized frail elderly patients – atrial fibrillation, anticoagulation and 12 months’ outcomes
por: Ekerstad, Niklas, et al.
Publicado: (2018)

Tolerating the Nervous System: A Delicate Balance
por: Huseby, Eric S., et al.
Publicado: (2000)

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial
por: Joosten, Linda P T, et al.
Publicado: (2019)

Linezolid for Treating Tuberculosis: A Delicate Balancing Act
por: Maartens, Gary, et al.
Publicado: (2015)

Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

External validation and updating of prediction models of bleeding risk in patients with cancer receiving anticoagulants
por: Trinks-Roerdink, EM, et al.
Publicado: (2023)

A delicate balance()
por: Grant-Kels, Jane M.
Publicado: (2018)

A delicate balance
Publicado: (1997)

Real-world characteristics of hospitalized frail elderly patients with atrial fibrillation: can we improve the current prescription of anticoagulants?
por: Annoni, Giorgio, et al.
Publicado: (2016)

Non-vitamin K antagonist oral anticoagulants in older and frail patients with atrial fibrillation
por: Giugliano, Robert P
Publicado: (2022)

The delicate balance of melanoma immunotherapy
por: Gyorki, David E, et al.
Publicado: (2013)

Reaching the Frail Elderly for the Diagnosis and Management of Atrial Fibrillation—REAFEL
por: Bamberg, Carsten, et al.
Publicado: (2023)

Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial
por: Trinks-Roerdink, E M, et al.
Publicado: (2023)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

Perioperative bridging anticoagulation for atrial fibrillation—the first randomised controlled trial
por: Wight, James Matthew, et al.
Publicado: (2016)

THU405 A Delicate Balance
por: Mohan, Nikita, et al.
Publicado: (2023)

Monochorionic Twins: A Delicate Balance
por: Lopriore, Enrico, et al.
Publicado: (2019)

Cathepsin D—Managing the Delicate Balance
por: Mijanovic, Olja, et al.
Publicado: (2021)

Anticoagulation in Elderly Patients With Atrial Fibrillation and Renal Dysfunction
por: Cheung, Christopher C., et al.
Publicado: (2023)

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Risks of anticoagulation in patients with chronic kidney disease and atrial fibrillation: More than just bleeding?
por: Gutiérrez, Orlando M.
Publicado: (2019)

Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2022)

Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation
por: Cavallari, Ilaria, et al.
Publicado: (2018)

Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2022)

The Proteasome and the Delicate Balance between Destruction and Rescue
por: Glickman, Michael H, et al.
Publicado: (2004)

Development of Spinal Cord Neurons in Delicate Balance
por: Sedwick, Caitlin
Publicado: (2014)

Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document
por: Proietti, Marco, et al.
Publicado: (2022)

A systematic review and meta-analysis of diagnostic delay in pulmonary embolism
por: van Maanen, R., et al.
Publicado: (2022)

Determinants of label non-adherence to non-vitamin K oral anticoagulants in patients with newly diagnosed atrial fibrillation
por: Seelig, J, et al.
Publicado: (2022)

Anticoagulation for Atrial Fibrillation in the Very Elderly: Make or Break?
por: Makimoto, Hisaki
Publicado: (2022)

Is dual therapy the correct strategy in frail elderly patients with atrial fibrillation and acute coronary syndrome?
por: Menditto, Alessio, et al.
Publicado: (2020)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
por: de Padua Mansur, Antonio, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis
por: Tsigkas, Grigorios, et al.
Publicado: (2021)

Disrupting a delicate balance: environmental effects on the thyroid.
por: Brown, Valerie J
Publicado: (2003)

A delicate balance: Iron metabolism and diseases of the brain
por: Hare, Dominic, et al.
Publicado: (2013)

Air Quality and Climate Change: A Delicate Balance
por: Tibbetts, John H.
Publicado: (2015)

Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
por: Lindley, Richard I
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9ksscofsh1a17a2gnbebmdbluk